The All India Institute of Medical Sciences (AIIMS) has released the list of eligible candidates for professional ...

Circulation: Cardiovascular Quality and Outcomes will include high-quality applied clinical, epidemiological, and health care policy papers related to cardiovascular diseases. The mission of the ...

More than 12% of Americans will develop a thyroid condition at some point, with women at greater risk than men.

The Endocrine Society was established in 1915 for ... during pregnancy may experience long-term weight gain and heart problems later in life, according to new research, published in The Journal ...

Type 2 diabetes and cardiovascular disease are significant health concerns, with each being a leading cause of death worldwide. Medical News Today spoke with Avantika Waring, MD, a board-certified ...

Abbott Laboratories is a large-cap company that makes medical devices, including continuous glucose monitoring (CGM) systems, defibrillators, heart failure ... Intuitive Surgical is a large ...

It indicates an expandable section or menu, or sometimes previous / next navigation options. Affiliate links for the products on this page are from partners that compensate us (see our advertiser ...

Obtaining a life insurance policy can be a hassle — you have to apply, get a medical exam and wait for an underwriting decision that can take days or weeks. No-exam life insurance skips the ...

KEY POINTS A 33-year-old woman presented to our outpatient endocrinology clinic with worsening hypertension (clinic blood pressure reading 169/112 mm Hg) despite treatment with perindopril 4 mg daily.

With the prevalence of cardiovascular disease, it is imperative that medical monitoring and treatment become more instantaneous and comfortable for patients. Recently, wearable and implantable ...

Q I would like to know why it is that so many medications have side effects. Is it the medications themselves, or is it the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved two new indications for KEYTRUDA ® (pembrolizumab), Merck’s anti ...